About
Ophthalmology Gene Therapy
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyChina
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
2
As Collaborator
0
Total Enrollment
23
By Phase
PHASE1/PHASE2: 2
By Status
TERMINATED: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2022
2023
2024
2025
2026
2027
2028
2029
2030
Today
Hover over trial bars to see details
Recent Trials
NCT05820152Lead Sponsor
Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND1 Mutations
PHASE1/PHASE2Terminated
11 participants
Started: Aug 15, 2023 · Completed: Jun 24, 2024
NCT05293626Lead Sponsor
Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations
PHASE1/PHASE2Active, not recruiting
12 participants
Started: May 22, 2023 · Completed: Dec 31, 2029
Locations (1)
Headquarters
Wuhan, China
Map
Loading map...